2,7-Dibromo-9-hexyl-9H-carbazole

Introduction

CAS No. :	654676-12-7	MDL No. :	MFCD29089359
Formula :	C18H19Br2N	Boiling Point :	No data available
Linear Structure Formula :	-	InChI Key :	YSUUFISKPJBPOH-UHFFFAOYSA-N
M.W :	409.16	Pubchem ID :	25150458
Synonyms :

Physicochemical Properties

Num. heavy atoms :	21
Num. arom. heavy atoms :	13
Fraction Csp3 :	0.33
Num. rotatable bonds :	5
Num. H-bond acceptors :	0.0
Num. H-bond donors :	0.0
Molar Refractivity :	100.14
TPSA :	4.93 Ų

Pharmacokinetics

GI absorption :	Low
BBB permeant :	No
P-gp substrate :	Yes
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	Yes
CYP2C9 inhibitor :	Yes
CYP2D6 inhibitor :	Yes
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-3.83 cm/s

Lipophilicity

Log Po/w (iLOGP) :	4.27
Log Po/w (XLOGP3) :	6.99
Log Po/w (WLOGP) :	6.9
Log Po/w (MLOGP) :	5.57
Log Po/w (SILICOS-IT) :	6.16
Consensus Log Po/w :	5.98

Druglikeness

Lipinski :	1.0
Ghose :	None
Veber :	0.0
Egan :	1.0
Muegge :	2.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-6.91
Solubility :	0.0000505 mg/ml ; 0.000000123 mol/l
Class :	Poorly soluble
Log S (Ali) :	-6.91
Solubility :	0.0000505 mg/ml ; 0.000000124 mol/l
Class :	Poorly soluble
Log S (SILICOS-IT) :	-8.16
Solubility :	0.00000282 mg/ml ; 0.0000000069 mol/l
Class :	Poorly soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	2.0
Synthetic accessibility :	2.09

Signal Word:	Warning	Class:
Precautionary Statements:	P261-P305+P351+P338	UN#:
Hazard Statements:	H302-H315-H319-H335	Packing Group:
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine